Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Brett Lauring

8PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiologyElectrochemical energy storage and conversionMolecular targetsFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Jan 08, 2019
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial.

Silvina Gallo, Bernard Charbonnel, Allison Goldman

|Feb 09, 2018
Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study.

Ronnie Aronson, Juan Frias, Allison Goldman

|Jan 10, 2018
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study.

Sam Miller, Tania Krumins, Haojin Zhou

|Dec 29, 2017
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study.

Priscilla Hollander, Jie Liu, Julie Hill

|Dec 22, 2017
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.

Richard E Pratley, Roy Eldor, Annaswamy Raji

|Nov 22, 2017
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study.

George Grunberger, Sarah Camp, Jeremy Johnson

Pageof 2

Frequent Collaborators

5 joint publications

Steven G Terra

2 joint publications

Allison Goldman

1 joint publications

Ronnie Aronson

1 joint publications

Juan Frias

Frequent Collaborators

5 joint publications

Steven G Terra

2 joint publications

Allison Goldman

1 joint publications

Ronnie Aronson

1 joint publications

Juan Frias

Top Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on : Feb 28, 2013

26.5K
Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on : May 12, 2023

2.0K
Static Strength Training Method for Type 2 Diabetic Mice
03:17

Static Strength Training Method for Type 2 Diabetic Mice

Published on : Mar 29, 2024

1.1K
See more related videos

Top Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on : Feb 28, 2013

26.5K
Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on : May 12, 2023

2.0K
Static Strength Training Method for Type 2 Diabetic Mice
03:17

Static Strength Training Method for Type 2 Diabetic Mice

Published on : Mar 29, 2024

1.1K
See more related videos